Literature DB >> 17551016

Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine.

Hanna Stenstad1, Marcus Svensson, Helena Cucak, Knut Kotarsky, William W Agace.   

Abstract

The CC chemokine receptor (CCR)9 is expressed on the majority of small intestinal, but few colonic, T cells, whereas its ligand CCL25 is constitutively expressed by small intestinal epithelial cells. As such, CCR9/CCL25 have been proposed to play a central role in regulating small intestinal but not colonic immune responses and thus to organize regionalized immunity within the intestinal mucosa. Here, we demonstrate that CCL25 is expressed at reduced levels by epithelial cells in the distal compared with proximal small intestine, which correlated with less efficient CCR9-dependent effector CD8alphabeta+ T cell entry into the ileal epithelium. In vitro-generated alpha4beta7+ effector CD8alphabeta+ T cell entry into the lamina propria was less dependent on CCR9 than entry into the epithelium along the entire length of the small intestine and in particular in the ileum. CCR9-independent alpha4beta7+ effector CD8alphabeta+ T cell entry was pertussis toxin-sensitive, suggesting a role for additional Galpha(I)-linked G protein-coupled receptors. Finally, in vivo-primed effector CD8alphabeta+ T cells displayed regionalized differences in their entry to the small intestinal epithelium with enhanced CCR9-independent entry to the ileum. These results highlight a hitherto underappreciated compartmentalization of immune responses within the small intestine and have direct implications for targeting strategies aimed at regulating T cell localization to the small intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551016      PMCID: PMC1891238          DOI: 10.1073/pnas.0700269104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  A role for CCR9 in T lymphocyte development and migration.

Authors:  Shoji Uehara; Alexander Grinberg; Joshua M Farber; Paul E Love
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.

Authors:  K A Papadakis; J Prehn; S T Moreno; L Cheng; E A Kouroumalis; R Deem; T Breaverman; P D Ponath; D P Andrew; P H Green; M R Hodge; S W Binder; S R Targan
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

3.  The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system.

Authors:  K A Papadakis; J Prehn; V Nelson; L Cheng; S W Binder; P D Ponath; D P Andrew; S R Targan
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

4.  Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.

Authors:  Jesús Rivera-Nieves; Johnson Ho; Giorgos Bamias; Natalia Ivashkina; Klaus Ley; Martin Oppermann; Fabio Cominelli
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

5.  Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.

Authors:  M A Wurbel; M Malissen; D Guy-Grand; E Meffre; M C Nussenzweig; M Richelme; A Carrier; B Malissen
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9.

Authors:  M A Wurbel; J M Philippe; C Nguyen; G Victorero; T Freeman; P Wooding; A Miazek; M G Mattei; M Malissen; B R Jordan; B Malissen; A Carrier; P Naquet
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

7.  Functional characterization of the CCL25 promoter in small intestinal epithelial cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription factors.

Authors:  Anna Ericsson; Knut Kotarsky; Marcus Svensson; Mikael Sigvardsson; William Agace
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

8.  Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

9.  Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.

Authors:  Bengt Johansson-Lindbom; Marcus Svensson; Oliver Pabst; Caroline Palmqvist; Gabriel Marquez; Reinhold Förster; William W Agace
Journal:  J Exp Med       Date:  2005-10-10       Impact factor: 14.307

10.  Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.

Authors:  E J Kunkel; J J Campbell; G Haraldsen; J Pan; J Boisvert; A I Roberts; E C Ebert; M A Vierra; S B Goodman; M C Genovese; A J Wardlaw; H B Greenberg; C M Parker; E C Butcher; D P Andrew; W W Agace
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  37 in total

1.  Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa.

Authors:  Natasa Strbo; Monica Vaccari; Savita Pahwa; Michael A Kolber; Eva Fisher; Louis Gonzalez; Melvin N Doster; Anna Hryniewicz; Barbara K Felber; George N Pavlakis; Genoveffa Franchini; Eckhard R Podack
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Comprehensive assessment of chemokine expression profiles by flow cytometry.

Authors:  Jens Eberlein; Tom T Nguyen; Francisco Victorino; Lucy Golden-Mason; Hugo R Rosen; Dirk Homann
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

3.  Oral vaccines: directed safe passage to the front line of defense.

Authors:  Qing Zhu; Jay A Berzofsky
Journal:  Gut Microbes       Date:  2013-03-14

Review 4.  The integration of T cell migration, differentiation and function.

Authors:  David Masopust; Jason M Schenkel
Journal:  Nat Rev Immunol       Date:  2013-04-19       Impact factor: 53.106

Review 5.  Regional specialization within the intestinal immune system.

Authors:  Allan M Mowat; William W Agace
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

6.  Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice.

Authors:  Barbara Cassani; Eduardo J Villablanca; Francisco J Quintana; Paul E Love; Adam Lacy-Hulbert; William S Blaner; Tim Sparwasser; Scott B Snapper; Howard L Weiner; J Rodrigo Mora
Journal:  Gastroenterology       Date:  2011-09-16       Impact factor: 22.682

7.  Enhanced differentiation of intraepithelial lymphocytes in the intestine of polymeric immunoglobulin receptor-deficient mice.

Authors:  Noriko Kato-Nagaoka; Shin-Ichiro Shimada; Yoko Yamakawa; Satoshi Tsujibe; Tomoaki Naito; Hiromi Setoyama; Yohei Watanabe; Kan Shida; Satoshi Matsumoto; Masanobu Nanno
Journal:  Immunology       Date:  2015-06-26       Impact factor: 7.397

Review 8.  Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.

Authors:  D R Kaufman; D H Barouch
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.

Authors:  Nainong Li; Ying Chen; Wei He; Tangsheng Yi; Dongchang Zhao; Chunyan Zhang; Chia-Lei Lin; Ivan Todorov; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

10.  CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system.

Authors:  Luciana Benevides; Cristiane Maria Milanezi; Lucy Megumi Yamauchi; Cláudia Farias Benjamim; João Santana Silva; Neide Maria Silva
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.